选择性环氧合酶-2抑制剂对结直肠肿瘤的预防和治疗作用
出处
《胃肠病学》
2005年第5期311-314,共4页
Chinese Journal of Gastroenterology
参考文献21
-
1Chiu CH, McEntee MF, Whelan J. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Res, 1997, 57:4267～4273.
-
2Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer, 2001, 1: 11～21.
-
3Araki Y, Okamura S, Hussain SP, Nagashima M, He P,Shiseki M, Miura K, Harris CC. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res, 2003, 63: 728～734.
-
4Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic,pharmacologic, and clinical issues. J Natl Cancer Inst,2002, 94: 252～266.
-
5Steinbach G, Lynch PM, Phillips RK, Wallace MH,Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B. The effect of celecoxib,a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med, 2000, 342: 1946～1952.
-
6Masferrer JL. Cyclooxygenase-2 inhibitors in cancer prevention and treatment. Adv Exp Med Biol, 2003, 532:209～213.
-
7Azumaya M, Kobayashi M, Ajioka Y, Honma T, Suzuki Y, Takeuchi M, Narisawa R, Asakura H. Size-dependent expression of cyclooxygenase-2 in sporadic colorectal adenomas relative to adenomas in patients with familial adenomatous polyposis. Pathol Int, 2002, 52: 272～276.
-
8Nasir A, Kaiser HE, Boulware D, Hakam A, Zhao H,Yeatman T, Barthel J, Coppola D. Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy.Clin Colorectal Cancer, 2004, 3: 243～247.
-
9Wei M, Morimura K, Wanibuchi H, Shen J, Salim EI,Moku M, Hakoi K, Fukushima S. JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but notgrowth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats. Int J Cancer,2005, 113: 354～358.
-
10Tatsuguchi A, Matsui K, Shinji Y, Gudis K, Tsukui T,Kishida T, Fukuda Y, Sugisaki Y, Tokunaga A, Tajiri T,Sakamoto C. Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol, 2004, 35: 488～495.
-
1凌康,王颢.美洛昔康对人肝癌裸鼠原位移植瘤生长的抑制性影响的研究[J].中国组织化学与细胞化学杂志,2008,17(5):470-474. 被引量：1
-
2欧阳波,张有成,黄强.COX-2途径对胆管癌细胞血管内皮生长因子影响的实验研究[J].牡丹江医学院学报,2011,32(5):15-19.
-
3段瑞钦,刘建霞,赵素斌,沈香荣,李守霞.选择性环氧合酶-2抑制剂罗非昔布对胆囊癌生长的影响[J].山东医药,2007,47(27):17-19.
-
4梁新军,夏仁云,俞猛,夏侃.NS-398对骨肉瘤细胞的作用及其对Survivin表达的影响[J].中国矫形外科杂志,2005,13(13):1000-1002.
-
5刘纯伦,唐承薇,万学红,王春晖,周旭春.选择性环氧合酶-2抑制剂对胃癌细胞生长的影响[J].四川大学学报（医学版）,2003,34(3):480-483. 被引量：4
-
6龙成,姜永梅,李国权.选择性环氧合酶-2抑制剂在肿瘤放疗中的应用[J].国际肿瘤学杂志,2013,40(11):820-823.
-
7谢传高,王兴鹏,董育玮,蔡建庭,钱可大.选择性环氧合酶-2抑制剂Celebrex对胰腺癌血管内皮生长因子表达的影响[J].癌症,2003,22(10):1042-1046. 被引量：8
-
8王娟娟,许雪亮.环氧合酶-2及其选择性抑制剂对视网膜母细胞瘤细胞体外生长增殖的影响[J].国际眼科杂志,2007,7(5):1302-1304.
-
9杨武双,刘金凤,杨德林,岳武.选择性环氧合酶-2抑制剂对胶质瘤细胞增殖的抑制作用[J].中国肿瘤生物治疗杂志,2005,12(1):61-62.
-
10谢传高,王兴鹏,徐选福,蔡建庭,钱可大.选择性环氧合酶2-抑制剂Celebrex对胰腺癌新生血管生成的影响[J].基础医学与临床,2004,24(6):660-663. 被引量：4
